Ramiro Sanchez

Insider Reports History

Entity
Individual
Location
C/O Cerevell Therapeutics Holdings Inc., 131 Dartmouth Street Suite 502, Boston, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ramiro Sanchez:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Chief Medical Officer Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Medical Officer Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Rapport Therapeutics, Inc. Director Stock Option (Right to Buy) 29.8K Nov 7, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Medical Officer Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Ramiro Sanchez

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAPP Rapport Therapeutics, Inc. Nov 7, 2024 1 $0 4 Nov 7, 2024 Director
RAPP Rapport Therapeutics, Inc. Nov 7, 2024 0 $0 3 Nov 7, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Chief Medical Officer
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 Chief Medical Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 26, 2023 3 -$390K 4 Dec 28, 2023 Chief Medical Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 3 -$421K 4 Dec 21, 2023 Chief Medical Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 15, 2023 3 -$236K 4 Dec 19, 2023 Chief Medical Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 7, 2023 3 -$379K 4 Dec 11, 2023 Chief Medical Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2023 2 $0 4 Feb 8, 2023 Chief Medical Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 9, 2022 1 $0 4 Feb 11, 2022 Chief Medical Officer